CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Complications

ONCOLOGY. Vol. 24 No. 8
COMMENTARY 

Osteoporosis, Fractures, and Risk of Falls

The Balducci Article Reviewed [READ ARTICLE]

By Melissa J. Cohen, MD1, Arash Naeim, MD, PhD2 | July 21, 2010
1 Fellow in Geriatric Oncology, UCLA David Geffen, School of Medicine, Los Angeles, California
2 Associate Professor, Director, Fellowship Program, in Geriatric Oncology, UCLA David Geffen, School of Medicine, Los Angeles, California

Osteoporosis in elderly cancer patients is an increasing problem, yet it remains under-recognized and under-managed. We commend Dr. Balducci for writing a comprehensive review of the bone complications associated with cancer and its treatment in the elderly. Dr. Balducci's review demonstrates why oncologists need to become better aware of the ill effects of cancer and its treatment on the bones of their elderly patients. The review clearly outlines the many important unanswered questions and research opportunities in this field. Osteopenia and osteoporosis are generally silent diseases until they are complicated by fractures. Considering that most fractures among older adults are caused by falls,[1] this commentary outlines how to assess which older cancer patient is at risk of fracture and which older cancer patient is at risk for falling in order to prevent significant injury.

TABLE 1
Risk Factors for Falls

Who Is at Risk of Fracture?
Morbidity associated with osteoporosis is due to fractures, therefore assessing risk of a fracture is important. Such assessment involves the identification and modification of clinical risk factors, in addition to measuring a person's bone density. The National Osteoporosis Foundation recommends a comprehensive approach to diagnosing osteoporosis including a detailed history and physical, medication assessment, and use of the Fracture Risk Assessment tool (FRAX).[2] The FRAX tool, developed by the World Health Organization (WHO), is an algorithm that estimates the 10-year probability of a hip fracture or osteoporotic fracture. Clinical features such as sex, weight, height, history of prior fracture, family history of hip fracture, smoking status, steroid use, rheumatoid arthritis diagnosis, and alcohol(Drug information on alcohol) consumption are utilized. The tool was developed in population-based cohorts from Europe, North America, Australia, and Japan in subjects more than 50 years of age, and it has been demonstrated to be valid and reliable. A web-based version is available at http://www.shef.ac.uk/FRAX/.[3]

(MORE: Bone Complications of Cancer Treatment in the Elderly)

Who Is at Risk for Falls?
Since the majority of osteoporosis-related fractures result from falls,[1] it is important for oncologists caring for older at-risk patients to identify and modify risk factors for falling. One in three adults over the age of 65 falls each year.[4,5] Falls are the leading cause of accidental death in older people and the most common problem leading to loss of independence.[6,7] The average health care cost of a fall injury is more than $20,000.[8] The functional impairment resulting from the fall often leads the patient to become dependent, and functioning remains below prefall levels.[9] A risk assessment for falling considers the features of the patient, his or her environment, medication use, and personal habits. Significant risk factors have been elucidated in the geriatric literature and are included in Table 1.

Overcash and colleagues, in a prospective geriatric assessment of elderly patients undergoing cancer treatment vs age-matched controls, and using unadjusted rates, found that cancer patients were more likely to fall. They also found that among the patients with cancer, scores on the Activities of Daily Living (ADL) scale were a significant predictor of falls.[10]

Future Research
It is well established that one-third of all community-dwelling individuals over the age of 65 years fall every year.[11,12] Cancer and its treatments can increase an elderly patient's risk for falling by contributing to muscle weakness, osteoporosis, neuropathy, and fatigue, all of which can be considered risk factors for falling and subsequent fractures. Therefore, it may be important for oncologists caring for elderly cancer patients to be aware of the risk factors associated with osteoporosis, fractures, and falls. There are many opportunities for further research in this area. Areas that would benefit from more focused research include the prevalence of osteoporosis, falls, and fractures in patients undergoing chemotherapy; effects of chemotherapy-induced menopause or hypogonadism on bone health and fracture-risk differences in bone density, fall risk, and subsequent fractures in patients who have bone metastases vs those who do not;

functional and mortality outcomes for elderly cancer patients who fall vs those who do not fall; biological factors associated with bone loss, such as sarcopenia, malnutrition, or frailty; and design and implementation of interventions in an older cancer population found on assessment to be at risk of falling.

Dr. Balducci's article clearly outlines how cancer affects bone health. The next important step is to identify those at risk for falling in order to prevent fractures and subsequent morbidity and mortality.

Financial Disclosure: The authors have no significant financial interest or other relationship with the manufacturers of any products or providers of any service mentioned in this article.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This commentary refers to the following article

Bone Complications of Cancer Treatment in the Elderly





References

1. Bell AJ, Talbot-Stern JK, Hennessy A, Characteristics and outcomes of older patients presenting to the emergency department after a fall: A retrospective analysis. Med J Aust 173:179-182, 2000.

2. National Osteoporosis Foundation: Clinicians Guide to Prevention and Treatment of Osteoporosis. Available at www.nof.org/professionals/Clinicians-Guide.htm. Accessed June 22, 2010.

3. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK: FRAX: WHO Fracture Risk Assessment Tool. Available at http://www.shef.ac.uk/FRAX. Accessed June 22, 2010.

4. Hausdorff JM, Rios DA, Edelberg HK: Gait variability and fall risk in community-living older adults: A 1-year prospective study. Arch Phys Med Rehabil 82:1050-1056, 2001.

5. Hornbrook MC, Stevens VJ, Wingfield DJ, et al: Preventing falls among community-dwelling older persons: Results from a randomized trial. Gerontologist 34:16-23, 1994.

6. Alexander BH, Rivara FP, Wolf ME: The cost and frequency of hospitalization for fall-related injuries in older adults. Am J Public Health 82:1020-1023, 1992.

7. Sterling DA, O’Connor JA, Bonadies J: Geriatric falls: Injury severity is high and disproportionate to mechanism. J Trauma 50:116-119, 2001.

8. Rizzo JA, Friedkin R, Williams CS, et al: Health care utilization and costs in a Medicare population by fall status. Med Care 36:1174-1188, 1998.

9. Stel VS, Pluijm SM, Deeg DJ, et al: Functional limitations and poor physical performance as independent risk factors for self-reported fractures in older persons. Osteoporos Int 15:742-750, 2004.

10. Overcash JA, Beckstead J: Predicting falls in older patients using components of a comprehensive geriatric assessment. Clin J Oncol Nurs 12:941-949, 2008.

11. Tinetti ME: Clinical practice: Preventing falls in elderly persons. N Engl J Med 348:42-49, 2003.

12. Rubenstein LZ, Josephson KR: The epidemiology of falls and syncope. Clin Geriatr Med 18:141-158, 2002.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 

 
PUBLICATIONS
ONCOLOGY Journal ONCOLOGY Nurse Edition Journal Cancer Management: A Multidisciplinary Approach

ONCOLOGY

ONCOLOGY:
Nurse Edition

CANCER
MANAGEMENT
:
A Multidisciplinary
Approach


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica SEARCH RESULTS

Find peer-reviewed literature and websites for practicing medical professionals

CME on Oncologic Complications
Evidence on Oncologic Complications
Guidelines on Oncologic Complications
Patient Education on Oncologic Complications
Clinical Trials on Oncologic Complications
Practical Articles on Oncologic Complications
Research and Reviews on Oncologic Complications
All "Oncologic Complications" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy